C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2004
11/10/2004	EP1475441A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/10/2004	EP1475440A2 Growth differentiation factor-3
11/10/2004	EP1475436A1 Swine rag-1 gene and utilization thereof
11/10/2004	EP1475101A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1475100A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1474682A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
11/10/2004	EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/10/2004	EP1474521A2 An herpes simplex virus complex
11/10/2004	EP1474517A2 Mutated gene coding for a lat protein and the biological applications thereof
11/10/2004	EP1474451A2 De-immunized (poly)peptide constructs
11/10/2004	EP1474450A2 A novel target to inhibit angiogenesis
11/10/2004	EP1474449A2 Human antibodies for use as a therapeutic agent against vaccinia or small pox
11/10/2004	EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474444A1 A novel splice variant of myd88 and uses thereof
11/10/2004	EP1474169A2 Means and methods for altering the motility of the gastrointestinal tract
11/10/2004	EP1474168A1 7s immunoglobulin for treatment of choroidal neovascularisation
11/10/2004	EP1474167A2 Novel proteins in enteroaggregative esheriachia coli (eaec) useful for diagnosis and therapy of eaec infections
11/10/2004	EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/10/2004	EP1166112A4 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same
11/10/2004	EP1012280B1 Trimerising module
11/10/2004	EP0760852B1 Immunosuppressant target proteins
11/10/2004	CN1545552A Genes and proteins, and their uses
11/10/2004	CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004	CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004	CN1544471A Bovine mastitis resistant yolk antibody and its preparation method and formulation
11/10/2004	CN1544467A Variable region gene of high neutralization activity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544466A Variable region gene of high affinity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544464A Peptides
11/10/2004	CN1544090A Pig immunoglobulin contained oral medicine
11/10/2004	CN1175111C Method for integrating genes at specific sites in mammalian cells and vector used in it
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/09/2004	US6815581 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/09/2004	US6815540 Improved solubility/yield/ease of handling; fusion proteins; for diagnostics/drugs/research
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815201 HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies
11/09/2004	US6815183 For preventing infection of mosquitoes/transmission of malaria; drug screening; vaccines
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6815175 Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
11/09/2004	US6815160 By screening blood; kits; comprises anti-human/mono/polyclonal antibody-virus complexes; solid phase synthesis
11/09/2004	US6814970 Present on the surface of borrelia burgdorferi cells that lack the outer membrane proteins ospa, ospb, ospc and ospd; sensitive to cleavage with proteinase k; having binding affinity for certain monoclonal antibodies
11/09/2004	US6814968 Inhibition of viral infection and spread with viral and RhoA-derived peptides
11/09/2004	US6814967 Polypeptides
11/09/2004	US6814966 Monoclonal or polyclonal antibody which inhibits or antangonizes tnf- alpha, such as infliximab, thereby treating the subject with glaucoma
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814951 High levels of acetaldehyde and production of malondialdehyde following alcohol ingestion chemically combine in a synergistic manner creating a new hybrid adduct formed with hepatic proteins
11/09/2004	CA2035381C Preparation and use of gene banks of human antibodies ("human-antibody libraries")
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004094673A2 Methods for monitoring drug activities in vivo
11/04/2004	WO2004094640A1 Avian transgenesis using a chicken ovalbumin gene region
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094612A2 Cancer specific monoclonal antibodies
11/04/2004	WO2004094607A2 Methods of therapy and diagnosis using targeting of cells that express a human transporter-like protein
11/04/2004	WO2004094603A2 Transgenic mouse with simplified dh locus
11/04/2004	WO2004094598A2 Methods of use for novel human polypeptides encoded by polynucleotides
11/04/2004	WO2004094477A1 Recombinant antibodies and fragments recognising ganglioside n-glycolyl-gm3 and use thereof in the diagnosis and treatment of tumours
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004094475A2 Tissue factor antibodies and uses thereof
11/04/2004	WO2004094474A1 Clostridium difficile focussed antibodies
11/04/2004	WO2004094473A2 Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
11/04/2004	WO2004094467A2 H. pylori antigens
11/04/2004	WO2004094459A2 Polypeptides related to natriuretic peptides and methods of their identification and use
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093908A2 Compositions and methods for the therapy of inflammatory bowel disease
11/04/2004	WO2004093893A2 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
11/04/2004	WO2004093831A2 Cytokine-expressing cellular vaccine combinations
11/04/2004	WO2004093808A2 Novel tumor-associated antigens
11/04/2004	WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004	WO2004083373A3 Antibody against the g glycoprotein of respiraotry syncytial virus
11/04/2004	WO2004061104A3 Method for manufacturing recombinant polyclonal proteins
11/04/2004	WO2004050847A3 Modified antibodies stably produced in milk and methods of producing same
11/04/2004	WO2004048412A3 Method for the generation of antibodies against a desired antigen using preselected animals for immunization
11/04/2004	WO2004045525A3 Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
11/04/2004	WO2004043340A3 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
11/04/2004	WO2004035537A3 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
11/04/2004	WO2004032841A3 System for production and screening of monoclonal antibodies
11/04/2004	WO2004027043A3 Method for production of a multimeric protein by cell fusion
11/04/2004	WO2004024750A3 Cd44-binding ligands
11/04/2004	WO2004009618A3 Recombinant production of mixtures of antibodies
11/04/2004	WO2004003550A3 Individualization of therapy with anticoagulants
11/04/2004	WO2004002417A3 Mammalian ch1 deleted mimetibodies, compositions, methods and uses
11/04/2004	WO2004002223A3 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
11/04/2004	WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003076473A8 Specific ab1'-antibodies against tumour-associated antigen ca 125
11/04/2004	WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004	WO2003046573A3 Protein biopolymer markers predictive of insulin resistance
11/04/2004	WO2003021226A3 Peptide biomarker and method of identification
11/04/2004	WO2003015716A3 Immunoglobulin e vaccines and methods of use thereof
11/04/2004	WO2003000183A3 Method of treating atherosclerosis and other inflammatory diseases
11/04/2004	WO2002086070A3 Binding molecules for fc-region polypeptides
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof
11/04/2004	US20040221336 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/04/2004	US20040221334 Immunoglobulin for use in detection of modified insecticidal protein; immunodiagnostics and heterologous gene expression; tissue engineering and biological pest control
11/04/2004	US20040221327 Antibodies against autoantigens of primary billary cirrhosis and methods of making and using them
11/04/2004	US20040220396 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
11/04/2004	US20040220388 Novel heterodimeric fusion proteins
11/04/2004	US20040220383 Methods and materials relating to semaphorin-like polynucleotides

1 ... 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 ... 1494